Slottsviken Fastighetsaktiebolag (publ), a real estate company, acquires, develops, and manages properties in Sweden and internationally. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities. The company was formerly known as Conpharm AB (publ) and changed its name to Slottsviken Fastighetsaktiebolag (publ) in July 2015. The company was founded in 1983 and is headquartered in Gothenburg, Sweden.